That led a group of researchers from Australia to explore the possibility of a antifibrotic strategy that would inhibit the pathology in a number of organs. Their findings were published in Science ...
Leptomeningeal inflammation in a mouse model of multiple sclerosis triggers deeply penetrating gene changes in underlying brain tissue, described using spatial transcriptomics.